Immunology · Year 2 · from Immunology
Case 3: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1/APECED)
Patient Demographics
- Age: 9 years old
- Sex: Female
- Ethnicity: Finnish descent
Chief Complaint
Muscle cramps and recurrent oral thrush
History of Present Illness
A 9-year-old girl of Finnish descent presents with hand and foot muscle cramping and tingling for 2 weeks. She has a history of chronic oral thrush since age 3 that has been difficult to control. Her parents note that she has also developed patchy hair loss over the past year.
Past Medical History
- Chronic mucocutaneous candidiasis since age 3 (oral, esophageal, nail involvement)
- Alopecia areata starting at age 8
- Dental enamel hypoplasia (noted by dentist)
Family History
- Parents are first cousins (consanguineous)
- No known family history of autoimmune disease
Physical Examination
- General: Well-appearing girl
- Vital Signs: Normal
- HEENT: White plaques on tongue and buccal mucosa (oral candidiasis); dental enamel defects
- Skin: Patches of alopecia on scalp (alopecia areata pattern)
- Nails: Thickened, dystrophic fingernails (onychomycosis)
- Neurological: Positive Chvostek sign (facial muscle twitch with tapping over facial nerve); positive Trousseau sign (carpopedal spasm with BP cuff inflation)
Laboratory Workup
| Test | Result | Reference Range |
|---|---|---|
| Calcium | 6.2 mg/dL | 8.5-10.5 mg/dL |
| Phosphorus | 7.5 mg/dL | 3.0-5.5 mg/dL |
| PTH | 8 pg/mL | 15-65 pg/mL |
| Magnesium | Normal | -- |
| Cortisol (AM) | Normal | -- |
| ACTH stimulation test | Normal | -- |
| Anti-IFN-omega antibodies | Positive | Negative |
| Anti-IL-17A antibodies | Positive | Negative |
| Anti-IL-22 antibodies | Positive | Negative |
| AIRE gene | Homozygous mutation | Wild type |
Clinical Image
Image showing chronic oral candidiasis, one of the characteristic features of APECED/APS-1. Image source: Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Oral_thrush_adult.jpg). Licensed under CC BY-SA 4.0.
Diagnosis
Autoimmune Polyendocrine Syndrome Type 1 (APS-1)/APECED (Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy) due to AIRE gene mutation.
Discussion
APS-1/APECED is caused by autosomal recessive mutations in AIRE (Autoimmune Regulator), a transcription factor critical for central T cell tolerance:
AIRE's normal function:
- Expressed in medullary thymic epithelial cells
- Drives expression of tissue-restricted antigens (insulin, thyroglobulin, etc.) in the thymus
- Allows deletion of T cells reactive against these peripheral tissue antigens
- Without AIRE, autoreactive T cells escape to the periphery
Classic diagnostic triad (2 of 3 required):
- Chronic mucocutaneous candidiasis (CMC) - usually first manifestation, often by age 5
- Hypoparathyroidism - causes hypocalcemia (present in this case)
- Adrenal insufficiency - often develops later
Additional manifestations:
- Ectodermal dystrophy: Dental enamel hypoplasia, nail dystrophy
- Alopecia areata or totalis
- Vitiligo
- Autoimmune hepatitis
- Type 1 diabetes
- Autoimmune thyroiditis
- Pernicious anemia
- Autoimmune ovarian/testicular failure
Why does AIRE deficiency cause candidiasis?
- Patients develop neutralizing autoantibodies against IL-17A, IL-17F, and IL-22
- These cytokines are essential for mucosal defense against Candida
- The autoantibodies functionally impair Th17-mediated immunity
- This case demonstrates positive anti-IL-17 and anti-IL-22 antibodies
Epidemiology:
- More common in Finnish, Iranian Jewish, and Sardinian populations
- Autosomal recessive inheritance (consanguinity is a risk factor)
Treatment
- Hypoparathyroidism: Calcium and calcitriol (active vitamin D) supplementation
- Chronic mucocutaneous candidiasis: Long-term antifungal therapy (fluconazole, itraconazole)
- Surveillance for additional autoimmune manifestations:
- Annual screening for adrenal insufficiency (cortisol, ACTH)
- Monitor for diabetes, thyroid disease, hepatitis
- Hormone replacement: As needed for each endocrinopathy
- Genetic counseling: For autosomal recessive inheritance
- No disease-modifying therapy available: Treatment is supportive and directed at individual manifestations